The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has now enrolled more than 100,000 women in the United States and abroad. One of the fastest-growing National Cancer Institute-sponsored trials, TMIST has expanded to 130 participating clinical sites in the US, Argentina, Canada, Peru, Italy, South Korea, and now Thailand.
[ECOG-ACRIN Cancer Research Group]
